Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT sensitivity surveillance in Kenya
PACTR201111000316370Recruiting
- Start
- Mar 2010
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of artemether, lumefantrine, dihydroartemisinin and piperaquine in Malaria (2 arms). Primary endpoint: Risk of PCR-corrected parasitaemia following treatment. Started Mar 2010; status: recruiting.
02
Drugs
artemetherlumefantrinedihydroartemisininpiperaquine
03
Conditions
Malaria
Beyond the preview
Go deeper on PACTR201111000316370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201111000316370.